Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 109,050 shares at $26.52 ($2.8M) on 2016-05-04, disclosed to the SEC on 2016-05-06.
Open-market sale of $2.8M MCRB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.52 | 28,598 | $758K | 26.6% |
| 2 | $26.52 | 28,598 | $758K | 26.6% |
| 3 | $27.31 | 700 | $19K | 0.7% |
| 4 | $25.48 | 21,127 | $538K | 18.9% |
| 5 | $25.48 | 21,127 | $538K | 18.9% |
| 6 | $26.34 | 8,900 |
| $234K |
| 8.2% |
| Total | $26.11 avg | 109,050 | $2.8M | 100% |
| Filing → |
| RUBY | BUY | 2018-07-23 | $2K | — | Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |